Imetelstat
Geron Corporation
[]
first author presents results of the phase iii study #imerge today at 2:12pm cdt during the hematologic malignancies track. #asco23 #hematology #imetelstat 
Yale Cancer Center is a collaboration between renowned cancer researchers and physicians @Yale and @SmilowCancer.